Francisco, Mercedita T.
HRN: 08-04-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/20/2023
05/27/2023
IVTT
900mg
Q8
T/c Septic Postpartum Hemorrage
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes